• Something wrong with this record ?

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer

D. Cibula, R. Pötter, F. Planchamp, E. Avall-Lundqvist, D. Fischerova, C. Haie-Meder, C. Köhler, F. Landoni, S. Lax, JC. Lindegaard, U. Mahantshetty, P. Mathevet, WG. McCluggage, M. McCormack, R. Naik, R. Nout, S. Pignata, J. Ponce, D. Querleu,...

. 2018 ; 472 (6) : 919-936. [pub] 20180504

Language English Country Germany

Document type Journal Article, Practice Guideline

Persistent link   https://www.medvik.cz/link/bmc18024222
E-resources Online Full text

NLK ProQuest Central from 2003-01-01 to 1 year ago
Medline Complete (EBSCOhost) from 2011-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest) from 2003-01-01 to 1 year ago
Health & Medicine (ProQuest) from 2003-01-01 to 1 year ago

Links

PubMed 29725757
DOI 10.1007/s00428-018-2362-9
Knihovny.cz E-resources

BACKGROUND: Despite significant advances in the screening, detection, and treatment of preinvasive cervical lesions, invasive cervical cancer is the fifth most common cancer in European women. There are large disparities in Europe and worldwide in the incidence, management, and mortality of cervical cancer. OBJECTIVE: The European Society of Gynecological Oncology (ESGO), the European Society for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly develop clinically relevant and evidence-based guidelines in order to improve the quality of care for women with cervical cancer across Europe and worldwide. METHODS: The ESGO/ESTRO/ESP nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of cervical cancer (23 experts across Europe). To ensure that the guidelines are evidence based, the current literature identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group. The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 159 international reviewers, selected through ESGO/ESTRO/ESP and including patient representatives. RESULTS: The guidelines cover comprehensively staging, management, and follow-up for patients with cervical cancer. Management includes fertility sparing treatment; stage T1a, T1b1/T2a1, clinically occult cervical cancer diagnosed after simple hysterectomy; early and locally advanced cervical cancer; primary distant metastatic disease; cervical cancer in pregnancy; and recurrent disease. Principles of radiotherapy and pathological evaluation are defined.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18024222
003      
CZ-PrNML
005      
20180710095139.0
007      
ta
008      
180709s2018 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00428-018-2362-9 $2 doi
035    __
$a (PubMed)29725757
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Cibula, David $u Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital, Kateřinská 32, 121 08, Prague, Czech Republic. dc@davidcibula.cz.
245    14
$a The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer / $c D. Cibula, R. Pötter, F. Planchamp, E. Avall-Lundqvist, D. Fischerova, C. Haie-Meder, C. Köhler, F. Landoni, S. Lax, JC. Lindegaard, U. Mahantshetty, P. Mathevet, WG. McCluggage, M. McCormack, R. Naik, R. Nout, S. Pignata, J. Ponce, D. Querleu, F. Raspagliesi, A. Rodolakis, K. Tamussino, P. Wimberger, MR. Raspollini,
520    9_
$a BACKGROUND: Despite significant advances in the screening, detection, and treatment of preinvasive cervical lesions, invasive cervical cancer is the fifth most common cancer in European women. There are large disparities in Europe and worldwide in the incidence, management, and mortality of cervical cancer. OBJECTIVE: The European Society of Gynecological Oncology (ESGO), the European Society for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly develop clinically relevant and evidence-based guidelines in order to improve the quality of care for women with cervical cancer across Europe and worldwide. METHODS: The ESGO/ESTRO/ESP nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of cervical cancer (23 experts across Europe). To ensure that the guidelines are evidence based, the current literature identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group. The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 159 international reviewers, selected through ESGO/ESTRO/ESP and including patient representatives. RESULTS: The guidelines cover comprehensively staging, management, and follow-up for patients with cervical cancer. Management includes fertility sparing treatment; stage T1a, T1b1/T2a1, clinically occult cervical cancer diagnosed after simple hysterectomy; early and locally advanced cervical cancer; primary distant metastatic disease; cervical cancer in pregnancy; and recurrent disease. Principles of radiotherapy and pathological evaluation are defined.
650    _2
$a konsensus $7 D032921
650    _2
$a Evropa $7 D005060
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a gynekologie $x normy $7 D006176
650    _2
$a lidé $7 D006801
650    _2
$a lékařská onkologie $x normy $7 D008495
650    _2
$a patologové $x normy $7 D000072142
650    _2
$a radioterapie $x normy $7 D011878
650    _2
$a nádory děložního čípku $x diagnóza $x patologie $x rehabilitace $7 D002583
655    _2
$a časopisecké články $7 D016428
655    _2
$a směrnice pro lékařskou praxi $7 D017065
700    1_
$a Pötter, Richard $u Department of Radiotherapy, Medical University of Vienna, Vienna, Austria.
700    1_
$a Planchamp, François $u Institut Bergonié, Bordeaux, France.
700    1_
$a Avall-Lundqvist, Elisabeth $u Linkoping University, Linkoping, Sweden.
700    1_
$a Fischerova, Daniela $u Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital, Kateřinská 32, 121 08, Prague, Czech Republic.
700    1_
$a Haie-Meder, Christine $u Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France.
700    1_
$a Köhler, Christhardt $u Medical Faculty, Department of Gynecology, Asklepios Hambourg Altona and University of Cologne, Hamburg, Germany.
700    1_
$a Landoni, Fabio $u University of Milan Bicocca, Monza, Italy.
700    1_
$a Lax, Sigurd $u General Hospital Graz Sued-West, Graz, Austria.
700    1_
$a Lindegaard, Jacob Christian $u Department of Oncology, Aarhus University, Aarhus, Denmark.
700    1_
$a Mahantshetty, Umesh $u Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, India.
700    1_
$a Mathevet, Patrice $u Lausanne University, Lausanne, Switzerland.
700    1_
$a McCluggage, W Glenn $u Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK.
700    1_
$a McCormack, Mary $u University College Hospital London, London, UK.
700    1_
$a Naik, Raj $u Queen Elizabeth Hospital, Gateshead, UK.
700    1_
$a Nout, Remi $u Department of Radiation Oncology, Leiden University, Leiden, The Netherlands.
700    1_
$a Pignata, Sandro $u Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale," IRCCS, Naples, Italy.
700    1_
$a Ponce, Jordi $u University Hospital of Bellvitge (IDIBELL), Barcelona, Spain.
700    1_
$a Querleu, Denis $u Institut Bergonié, Bordeaux, France.
700    1_
$a Raspagliesi, Francesco $u Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
700    1_
$a Rodolakis, Alexandros $u Athens University, Athens, Greece.
700    1_
$a Tamussino, Karl $u Medical University of Graz, Graz, Austria.
700    1_
$a Wimberger, Pauline $u Dresden University, TU Dresden, Dresden, Germany.
700    1_
$a Raspollini, Maria Rosaria $u University Hospital, Careggi, Florence, Italy.
773    0_
$w MED00004660 $t Virchows Archiv an international journal of pathology $x 1432-2307 $g Roč. 472, č. 6 (2018), s. 919-936
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29725757 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180710095429 $b ABA008
999    __
$a ok $b bmc $g 1316353 $s 1021143
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 472 $c 6 $d 919-936 $e 20180504 $i 1432-2307 $m Virchows Archiv $n Virchows Arch $x MED00004660
LZP    __
$a Pubmed-20180709

Find record

Citation metrics

Archiving options